Article Versions Notes

Becherini P, Soncini D, Ravera S, Gelli E, Martinuzzi C, Giorgetti G, Cagnetta A, Guolo F, Ivaldi F, Miglino M, et al. CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD⁺-Lowering Agents. Antioxidants. 2023; 12(2):494. https://doi.org/10.3390/antiox12020494

Becherini, Pamela, Debora Soncini, Silvia Ravera, Elisa Gelli, Claudia Martinuzzi, Giulia Giorgetti, Antonia Cagnetta, Fabio Guolo, Federico Ivaldi, Maurizio Miglino, and et al. 2023. "CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD⁺-Lowering Agents" Antioxidants 12, no. 2: 494. https://doi.org/10.3390/antiox12020494

Becherini, P., Soncini, D., Ravera, S., Gelli, E., Martinuzzi, C., Giorgetti, G., Cagnetta, A., Guolo, F., Ivaldi, F., Miglino, M., Aquino, S., Todoerti, K., Neri, A., Benzi, A., Passalacqua, M., Nencioni, A., Perrotta, I., Gallo Cantafio, M. E., Amodio, N., ... Cea, M. (2023). CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD⁺-Lowering Agents. Antioxidants, 12(2), 494. https://doi.org/10.3390/antiox12020494